ScopeMedizinisches Versorgungszentrum am HELIOS Klinikum Emil von Behring GmbH Institut für Gewebediagnostik
7 capabilities
Accredited since April 2025
Verified May 2026
One of 3,188 in Germany
Details
Walterhöferstraße 11
Berlin 14165 , Germany
Berlin 14165 , Germany
Accreditation
Suspended
DAkkS
D-ML-20295-02-00
Specialises in molecular diagnostics for human genetics, employing next-generation sequencing and real-time PCR to detect cancer-associated mutations in blood, body fluids, and tissue samples. Testing focuses on molecular profiling for lung, colorectal, and pancreatic malignancies.
Accreditation Details
Accreditation Body
DAkkS
Number
D-ML-20295-02-00
Status
SuspendedSince
07 April 2025
Accreditation is granted under EU Regulation 765/2008 and assessed against ISO/IEC 17025. Data sourced from official DAkkS records.
Download Scope PDF
Test Capabilities (7)
| Standard Reference | Description | Category |
|---|---|---|
| Punktmutation | Punktmutation | Biocompatibility (ISO 10993) |
| KRAS Gen Punktmutation in Codons | KRAS Gen Punktmutation in Codons | Biological / Microbiological |
| MAP2K1, MET, NRAS, PIK3CA, ROS1 | MAP2K1, MET, NRAS, PIK3CA, ROS1 | Biological / Microbiological |
| 12 und 13 | 12 und 13 | Molecular Diagnostics / PCR |
| Hereditäres Pankreaskarzinom | Hereditäres Pankreaskarzinom | Molecular Diagnostics / PCR |
| Karzinom | Lungenkarzinom: EGF-Rezeptor | Molecular Diagnostics / PCR |
| und TP53 | und TP53 | Molecular Diagnostics / PCR |